Delivering the Added Dimension in Drug Discovery Services
Jubilant Biosys offers a large array of GLP and non-GLP preclinical toxicology studies to its customers. The studies, in which our toxicology services team has expertise (certified toxicologist by American Board of Toxicology, DABT and pathologist by Indian Board of Toxicologic Pathology, DIBTP), comprise of acute, sub-acute, sub-chronic studies in various test systems with different routes of administration, along with in-vitro/in-vivo genotoxicity studies. These studies are performed in compliance with global regulatory guidelines, ICH, OECD, etc. at Jubilant’s GLP certified toxicology lab in India.
We provide a comprehensive range of toxicology and safety pharmacology services in accordance with the international regulatory guidelines. With routine screening of compounds in the R&D phase, we assist in toxicological safety assessment to identify and eliminate the unsafe elements at the earliest stage in drug development.
Jubilant Biosys has the latest facilities to evaluate the candidate compounds in a professional manner that results in the timely delivery of the reports. The rich experience of our scientific team helps our customers meet their specific preclinical and other early-stage product development needs, enhance their decision-making process, and save their time and resources.
Acute Studies
Repeated Dose Toxicity Studies in Rodents (rats/mice/guinea pigs) and Non-Rodents (rabbits)
Safety Pharmacology (CNS) In-vivo
Different Routes of Administration
In-vitro Toxicology Services
In-vivo Toxicology Services
We offer Stand Alone Pathology Services (tissue processing through slide evaluation and reporting) for the in-life phase of toxicology and efficacy studies conducted elsewhere.
